“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Alumis
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects. Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunc...
| C-Level 9 | VP - Level16 |
| Director46 | Manager16 |
| Others54 | |
| Pain Points | Locations | Technologies |
|---|---|---|
| CRM Implementation | South San Francisco, CA | integrity, share |
| Compliance | South San Francisco, CA | quality assurance, communication, root cause analysis, risk, audit, integrity, compliance, assessment, share, operations |
| Content Writing | South San Francisco, CA | quality assurance, communication, root cause analysis, risk, audit, integrity, compliance, assessment, share, operations |
| Digital Transformation | South San Francisco, CA | quality assurance, communication, root cause analysis, risk, audit, integrity, compliance, assessment, share, operations |
| Embedded | South San Francisco, CA | quality assurance, communication, root cause analysis, risk, audit, integrity, compliance, assessment, share, operations |
Alumis looking to hire in BI in San Francisco Bay Area
Alumis looking to hire in Application Development in South San Francisco, CA
Alumis looking to hire in BI in San Francisco, CA
Gcp
Netsuite
Access
Air
Aws
Infrastructure management
Acceptance testing
Analytics
Archival
Assessment
Alumis Inc. is a precision medicines company with the mission to transform the lives of patients ...
View MoreAlumis Inc. is a precision medicines company with the mission to transform the lives of patients ...
View MoreAlumis said Wednesday that it has completed its merger with Acelyrin . Each Acelyrin shareholder will receive 0.4814 Alumis share for each Acelyrin share
Read MoreStrategic biotech merger strengthens pipeline of immune disease therapies with extended cash runway to 2027. Key details of the stock-for-stock transaction
Read MoreStockholders back strategic merger to strengthen immune disease research. Combined entity promises enhanced drug development capabilities.
Read MoreStockholders back merger creating specialized immunology biopharma. 0.4814 Alumis shares per ACELYRIN share in Q2 2025 deal. See growth potential.
Read MoreAt Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects. Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right...
Alumis operates in the Biotechnology research industry.
Alumis's revenue is $5.50m
Alumis has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.